Seaport Therapeutics, Inc.
SPTX
Jodie situation report
Seaport Therapeutics, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 17 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.
- SPTX's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if SPTX's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind SPTX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
PTCHFFiling-linked namepartnerJun 8, 2026 ▾
“In April 2024, we entered into an Asset Transfer Agreement, or the Asset Transfer Agreement, with PureTech Health LLC, or PureTech Health and PureTech LYT Inc., or PureTech LYT, pursuant to which PureTech Health and PureTech LYT agreed to contribute, convey,…”
PTCHFFiling-linked nameinvesteeJun 8, 2026 ▾
“29 Contractual Obligations and Commitments Asset Transfer Agreement with PureTech We were incorporated in April 2024 by PureTech LYT, as our sole stockholder, and upon formation issued 318 shares of our common stock to PureTech LYT.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
SPTX is currently a Follower in the organic co-movement group Financial & Industrial Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for SPTX; it is not active in the latest market snapshot.